High-risk HPV Infection and Biopsy-proven CIN1
1 clinical trials · Condition
◉ Watch High-risk HPV Infection and Biopsy-proven CIN1
| Record | Firm | Date |
|---|---|---|
| An Open-Label, Phase I, Escalating Dose Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of PDS0101 (NCT02065973) | PDS Biotechnology Corp. | 2014-02-01 |
Track High-risk HPV Infection and Biopsy-proven CIN1 automatically
Every clearance here is in the API, with alerts when new ones post.